ArticleFrontiers in pharmacology2017

CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.

Feng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.